[go: up one dir, main page]

AR079080A1 - COMPOSITION OF POLIVALENT IMMUNOGLOBULINS TO TREAT AN ALCOHOLIC OR METABOLIC HEPATIC CIRROSIS - Google Patents

COMPOSITION OF POLIVALENT IMMUNOGLOBULINS TO TREAT AN ALCOHOLIC OR METABOLIC HEPATIC CIRROSIS

Info

Publication number
AR079080A1
AR079080A1 ARP100104283A ARP100104283A AR079080A1 AR 079080 A1 AR079080 A1 AR 079080A1 AR P100104283 A ARP100104283 A AR P100104283A AR P100104283 A ARP100104283 A AR P100104283A AR 079080 A1 AR079080 A1 AR 079080A1
Authority
AR
Argentina
Prior art keywords
alcoholic
composition
immunoglobulins
polivalent
cirrosis
Prior art date
Application number
ARP100104283A
Other languages
Spanish (es)
Original Assignee
Lab Francais Du Fractionnement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lab Francais Du Fractionnement filed Critical Lab Francais Du Fractionnement
Publication of AR079080A1 publication Critical patent/AR079080A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Composicion de inmunoglobulinas humanas polivalentes (IglV) para una utilizacion en la prevencion y/o el tratamiento de una cirrosis hepática alcoholica o metabolica.Composition of polyvalent human immunoglobulins (IglV) for use in the prevention and / or treatment of alcoholic or metabolic liver cirrhosis.

ARP100104283A 2009-11-20 2010-11-19 COMPOSITION OF POLIVALENT IMMUNOGLOBULINS TO TREAT AN ALCOHOLIC OR METABOLIC HEPATIC CIRROSIS AR079080A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0958214A FR2952826B1 (en) 2009-11-20 2009-11-20 USE OF MULTIPURPOSE IMMUNOGLOBULINS FOR TREATING ALCOHOLIC OR METABOLIC HEPATIC CIRRHOSIS

Publications (1)

Publication Number Publication Date
AR079080A1 true AR079080A1 (en) 2011-12-21

Family

ID=42122872

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100104283A AR079080A1 (en) 2009-11-20 2010-11-19 COMPOSITION OF POLIVALENT IMMUNOGLOBULINS TO TREAT AN ALCOHOLIC OR METABOLIC HEPATIC CIRROSIS

Country Status (3)

Country Link
AR (1) AR079080A1 (en)
FR (1) FR2952826B1 (en)
WO (1) WO2011061454A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4458C1 (en) * 2014-06-19 2017-08-31 Мария ДАНУ Use of Polybiolin drug in patients with liver cirrhosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE501476C2 (en) 1992-10-21 1995-02-27 Nilsson Carl O Lennart Cylinder bolt mechanism at repeater rifle
IL135993A0 (en) * 2000-05-05 2001-05-20 Omrix Biopharmaceuticals Pharmaceutical composition for the treatment of fibrosis
FR2824568B1 (en) 2001-05-11 2004-04-09 Lab Francais Du Fractionnement PROCESS FOR THE PREPARATION OF HUMAN IMMUNOGLOBULIN CONCENTRATES FOR THERAPEUTIC USE
FR2853551B1 (en) 2003-04-09 2006-08-04 Lab Francais Du Fractionnement STABILIZING FORMULATION FOR IMMUNOGLOBULIN G COMPOSITIONS IN LIQUID FORM AND LYOPHILIZED FORM
FR2895263B1 (en) 2005-12-26 2008-05-30 Lab Francais Du Fractionnement CONCENTRATE OF IMMUNOGLOBIN G (LG) DEPLETED ANTI-A AND ANTI-B ANTIBODIES, AND POLYREACTIVE IGG

Also Published As

Publication number Publication date
WO2011061454A1 (en) 2011-05-26
FR2952826B1 (en) 2012-04-06
FR2952826A1 (en) 2011-05-27

Similar Documents

Publication Publication Date Title
EA201101117A1 (en) DPP-4 INHIBITORS FOR THE TREATMENT OF DIABETES IN CHILDREN
EA201001860A1 (en) DPP-4 inhibitors for the treatment of non-alcoholic fatty liver
CL2011000527A1 (en) Compounds derived from benzofuran; pharmaceutical composition that includes them; and their use in the treatment of hepatitis c.
SV2009003098A (en) ARILIMIDAZOLONAS AND ARILTRIAZOLONAS REPLACED AS INHIBITORS OF VASOPRESINE RECEPTORS
MX2008016453A (en) COMPOSITIONS AND METHODS TO TREAT PARASITE INFECTIONS.
CL2011002524A1 (en) Compounds of substituted 1,3-diazol-phenyl- (ethynyl, ethenyl or cyclopropyl) -phenyl-1,3-diazole substituted, ns5a inhibitors; pharmaceutical composition that includes them and their use in the treatment of hepatitis c.
MX386489B (en) IBAT INHIBITORS FOR THE TREATMENT OF LIVER DISEASES.
CL2012003026A1 (en) Pharmaceutical composition comprising pioglitazone and linagliptin; preparation procedure; Use in the treatment of type 2 diabetes or obesity.
GT201200276A (en) COMBINATIONS OF ACTIVE COMPOUNDS
CL2011000604A1 (en) Compounds derived from multiheteroaryl, h-pgds inhibitors, pharmaceutical composition comprising them; Useful in the treatment of inflammatory and allergic diseases.
CL2014002348A1 (en) Phenicol derived compounds; pharmaceutical composition that includes them; and its use to control or treat bacterial infections in cattle.
CL2011000846A1 (en) Heterocyclic Substituted Compounds; pharmaceutical composition; and its use for the treatment of hepatitis c.
BRPI0911612A2 (en) compositions and methods for the treatment of multiple sclerosis.
CL2011002548A1 (en) Compounds derived from resolviin; pharmaceutical composition; use of the composition; pharmaceutical kit; pharmaceutical combination; use of the compounds in the treatment and / or prevention of an ophthalmic condition.
BRPI0819931A2 (en) TOPIC COMPOSITIONS UNDERSTANDING NON PROTEGENIC AMINO ACIDS AND SKIN TREATMENT METHODS
BR112013014189A2 (en) pharmaceutical composition comprising transcinamaldehyde and its use in the treatment of infections
DK2040565T3 (en) COMPOSITIONS AND METHODS FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASES IN CATS WITH HYPERTHYROIDISM
CL2012001757A1 (en) 8-hydroxyquinoline-7-carboxamide derived compounds; pharmaceutical composition; and its use in the treatment of fungal infections.
CL2011001777A1 (en) Pharmaceutical composition containing aleglitazar; process to prepare said pharmaceutical composition; and its use for the treatment or prophylaxis of type II diabetes or cardiovascular diseases.
GT201200279A (en) COMBINATIONS OF ACTIVE PRINCIPLES
CR20110022A (en) NEW POSSIBILITIES OF FIGHT AGAINST GIARDIASIS
MX2015005734A (en) METHODS OF TREATMENT OF HEPATIC DISEASES.
PL2895180T3 (en) Composition for the prevention and treatment of acute and recurrent urinary tract infections
BR112012029747A2 (en) skin treatment composition, method for providing an antimicrobial effect to the skin and use of a skin composition
ES2445016B1 (en) VACCINE FOR THE TREATMENT / PREVENTION OF ESCUTICOCILIATOSIS IN FISH

Legal Events

Date Code Title Description
FB Suspension of granting procedure